Terms ending in 2029
Every in-force patent on F. Hoffmann-La Roche AG's record whose computed term ends in 2029, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 7,812,161 | Synthesis of GLYT-1 Inhibitors In force · High confidence | Hoffmann-La Roche, Inc. | In force | High confidence | |
| US 8,153,639 | Substituted Thieno- and Furano- Fused Pyrimidines as PI3K Inhibitors In force · High confidence | F. Hoffmann-La Roche AG | In force | High confidence | |
| US 9,085,448 | Crimping Device In force · High confidence | F. Hoffmann-La Roche AG | In force | High confidence | |
| US 8,894,716 | Method of Mapping Femoral Head for Acetabular Prosthesis Alignment In force · Medium confidence | F. Hoffmann-La Roche AG | In force | Medium confidence | |
| US 7,846,929 | Phosphoinositide 3-Kinase Inhibitor Compounds and Methods of Use In force · High confidence | F. Hoffmann-La Roche AG | In force | High confidence | |
| US 8,399,690 | 4,5-Dihydro-6-oxa-3-thia-1-aza-benzo[e]azulene Compounds In force · Medium confidence | F. Hoffmann-La Roche AG | In force | Medium confidence | |
| US 8,846,762 | Benzopyran and Benzoxepin PI3K Inhibitor Compounds and Methods of Use In force · Medium confidence | Hoffmann-La Roche Inc. | In force | Medium confidence | |
| US 9,309,265 | Benzopyran and Benzoxepin PI3K Inhibitor Compounds and Methods of Use In force · Low confidence | Hoffmann-La Roche Inc. | In force | Low confidence | |
| US 7,893,059 | Thiazolopyrimidine P13K Inhibitor Compounds and Methods of Use In force · High confidence | F. Hoffmann - la Roche AG | In force | High confidence | |
| US 7,846,336 | Chromatographic Methods In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | |
| 18 more term ends in 2029 · Pro | |||||
10 of 28 patents shown. Soonest term end first, then patent number.
Pro members see all 28.
7 of these are in force and held by F. Hoffmann-La Roche AG.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.